Kite Pharma, Inc. Net Change in Cash
Kite Pharma, Inc. reported Net Change in Cash of $33.27 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-08-08
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$417.32M.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $450.59M.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$14.19M, a 106.45% decline year-over-year.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was -$41.41M.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$278.28M, a 251.62% decline from fiscal 2015.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $183.54M, a 1.82% decline from fiscal 2014.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $186.94M, a 1263.94% increase from fiscal 2013.
- Kite Pharma, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $13.71M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$417.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $33.27M 10-Q · filed 2017-08-08 | $19.09M derived: sum of 3 quarters · filed 2017-08-08 | -$22.32M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $450.59M 10-Q · filed 2017-05-08 | $436.40M derived: sum of 2 quarters · filed 2017-05-08 | $395.00M derived: sum of 3 quarters · filed 2017-05-08 | $365.55M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | -$14.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$55.60M derived: sum of 2 quarters · filed 2017-02-28 | -$85.04M derived: sum of 3 quarters · filed 2017-08-08 | -$278.28M 10-K · filed 2017-02-28 |
| 2016-09-30 | -$41.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$70.85M derived: sum of 2 quarters · filed 2017-08-08 | -$264.09M 10-Q · filed 2016-11-09 | -$44.22M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | -$29.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$222.69M 10-Q · filed 2017-08-08 | -$2.81M derived: sum of 3 quarters · filed 2017-08-08 | -$93.08M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$193.24M 10-Q · filed 2017-05-08 | $26.64M derived: sum of 2 quarters · filed 2017-05-08 | -$63.64M derived: sum of 3 quarters · filed 2017-05-08 | -$84.32M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $219.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $129.61M derived: sum of 2 quarters · filed 2017-02-28 | $108.92M derived: sum of 3 quarters · filed 2017-02-28 | $183.54M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$90.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$110.95M derived: sum of 2 quarters · filed 2016-11-09 | -$36.33M 10-Q · filed 2016-11-09 | $93.94M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$20.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $53.94M 10-Q · filed 2016-08-08 | $184.22M derived: sum of 3 quarters · filed 2017-02-28 | $59.84M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $74.62M 10-Q · filed 2016-05-09 | $204.90M derived: sum of 2 quarters · filed 2017-02-28 | $80.52M derived: sum of 3 quarters · filed 2017-02-28 | $265.29M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $130.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $5.90M derived: sum of 2 quarters · filed 2017-02-28 | $190.67M derived: sum of 3 quarters · filed 2017-02-28 | $186.94M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$124.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $60.39M derived: sum of 2 quarters · filed 2015-11-12 | $56.66M 10-Q · filed 2015-11-12 | $54.89M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $184.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $181.04M 10-Q · filed 2015-08-10 | $179.27M derived: sum of 3 quarters · filed 2016-02-29 | $177.47M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$3.73M 10-Q · filed 2015-05-15 | -$5.50M derived: sum of 2 quarters · filed 2016-02-29 | -$7.30M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.57M derived: sum of 2 quarters · filed 2016-02-29 | $13.71M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $15.48M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $17.27M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | -$2.53M 10-K · filed 2015-03-26 |